HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROMES

Authors

  • Fernando Barroso Duarte Hospital Universitário Walter Cantídio
  • Karine Sampaio Nunes Barroso
  • Roberto Luiz da Silva
  • Lívia Andrade Gurgel
  • João Paulo de Vasconcelos Leitão
  • Beatriz Stela Gomes de Souza Pitombeira
  • Rodolfo Daniel de Almeida Soares
  • Leandro de Pádua
  • Gustavo Betarello

DOI:

https://doi.org/10.46765/2675-374X.2023v4n1p178

Keywords:

Consensus, Update, Myelodysplastic Disease

Abstract

The document discuss key points in the management of patients with Myelodysplastic Disease, including therapeutic strategies, the role of new drugs available as well the Hematopoietic Stem Cell Transplantation. Other issues evaluated were importance of molecular alterations since diagnosis to prognosis, use of comprehensive geriatric assessment for  patient's selection, individualization of treatment, donor selection for HSCT and the role of  blasts % and molecular mutations for the appropriate diagnosis.

Downloads

Published

02/28/2023

How to Cite

Duarte, F. B. ., Karine Sampaio Nunes Barroso, Roberto Luiz da Silva, Lívia Andrade Gurgel, João Paulo de Vasconcelos Leitão, Beatriz Stela Gomes de Souza Pitombeira, Rodolfo Daniel de Almeida Soares, Leandro de Pádua, & Gustavo Betarello. (2023). HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROMES. JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY, 4(1), 178. https://doi.org/10.46765/2675-374X.2023v4n1p178

Issue

Vol. 4 No. 1 (2023): CONSENSUS UPDATE

Section

Original article

License

Copyright (c) 2023 JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Most read articles by the same author(s)

<< < 1 2 3 > >>